Revisiting problems and solutions to decrease Mycobacterium tuberculosis pyrazinamide false resistan...
Revisiting problems and solutions to decrease Mycobacterium tuberculosis pyrazinamide false resistance when using the Bactec MGIT 960 system
About this item
Full title
Author / Creator
Publisher
Rome: Istituto Superiore di Sanità
Journal title
Language
English
Formats
Publication information
Publisher
Rome: Istituto Superiore di Sanità
Subjects
More information
Scope and Contents
Contents
Pyrazinamide (PZA) is a first-line key drug used in combination with other agents for the treatment of tuberculosis (TB). Phenotypic and molecular assays for testing susceptibility of Mycobacterium tuberculosis (Mtb)to PZA have been developed, with the assay in liquid medium at acidic pH in the Bactec MGIT 960 (M960) system being routinely used in...
Alternative Titles
Full title
Revisiting problems and solutions to decrease Mycobacterium tuberculosis pyrazinamide false resistance when using the Bactec MGIT 960 system
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2640395252
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2640395252
Other Identifiers
ISSN
0021-2571
E-ISSN
2384-8553
DOI
10.4415/ANN_19_01_09
